Biodexa Pharmaceticals (BDRX)

US · Healthcare · Biotechnology

$0.80-16.67%

Last close · 2026-09-17

Latest quarter · ended 2025-12-31

Net profit

$-2.6M

EPS

$-15.06

EPS estimate

$0.00

Market cap

$867,903

Forward P/E

0.0

P/B

0.10

Book value

$34.02

EPS (TTM)

$-24.99

52-week high

$59.40

52-week low

$0.61

50-day MA

$1.49

200-day MA

$6.30

Beta

1.19

Analysts rate Biodexa Pharmaceticals a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $10.19.

Institutions

1.94%

Fund	Stake
Sabby Management LLC	5.00%
Armistice Capital, LLC	1.90%
GAMMA Investing LLC	0.12%
Allied Private Wealth LLC	0.05%
SBI Securities Co Ltd	0.00%
UBS Group AG	0.00%
Hilton Head Capital Partners, LLC	0.00%
Rhumbline Advisers	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Biodexa Pharmaceticals — free to start.

Data updated 2026-09-18.